[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:follicular-helper-t-cell-lymphoma-follicular-type":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":27,"states":28},"Follicular Helper T-Cell Lymphoma, Follicular-Type",3,[7,15,21],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05079282","Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma",[11],"Phase 1","RECRUITING","2026-08-26T02:17:12.307088Z","2026-05-05T02:43:29.642831Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT05010005","A Study of Ruxolitinib and Duvelisib in People With Lymphoma",[11],"2026-08-26T02:16:01.079019Z","2026-05-05T02:43:26.685721Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT05978141","A Registry for People With T-cell Lymphoma",[],"2026-08-26T02:16:20.336282Z","2026-05-13T02:55:06.403613Z",[],[29,32,35],{"state":30,"count":5,"slug":31},"Massachusetts","massachusetts",{"state":33,"count":5,"slug":34},"New Jersey","new-jersey",{"state":36,"count":5,"slug":37},"New York","new-york"]